Janus Henderson Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-52,917
| Closed | -$524K | – | 2659 |
|
|
2022
Q2 | $524K | Hold |
52,917
| – | – | ﹤0.01% | 1733 |
|
|
2022
Q1 | $523K | Hold |
52,917
| – | – | ﹤0.01% | 1895 |
|
|
2021
Q4 | $516K | Buy |
52,917
+6,318
| +14% | +$61.6K | ﹤0.01% | 1875 |
|
|
2021
Q3 | $464K | Hold |
46,599
| – | – | ﹤0.01% | 1652 |
|
|
2021
Q2 | $467K | Buy |
46,599
+26,599
| +133% | +$267K | ﹤0.01% | 1442 |
|
|
2021
Q1 | $198K | Buy |
+20,000
| New | +$198K | ﹤0.01% | 1509 |
|